2364. Surprising Prescribing: Treatment Practices following Addition of Toxin Testing to an Existing Molecular Test for Clostridioides difficile

BACKGROUND: Diagnosis of Clostridioides difficile infection (CDI) is problematic. Adding toxin enzyme immunoassay (EIA) to molecular tests may differentiate disease from colonization and reduce treatment. Detailed descriptions of prescribing patterns following the introduction of EIA testing are not...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Ryan, Morillas, Jose A, Fraser, Thomas G, Brizendine, Kyle D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810074/
http://dx.doi.org/10.1093/ofid/ofz360.2042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810074/
http://dx.doi.org/10.1093/ofid/ofz360.2042

Ejemplares similares